The G34-mutated tumors have been found to rely on the TGFB1 and HAVCR2 (TIM3) pathways for immune evasion [10] indicating that the underlying genetic makeup of the glioma may influence preferential dominant immune-suppressive mechanisms. The gene discussed is TGFB1; the disease is central nervous system cancer.